CD4 and neoplasm: TILs subsets including CD4, CD8, and FOXP3 should be evaluated, and the balance of tumor suppressive activity conferred by CD8+ Treg cells and CD4+ Treg cells and adaptive tumor responses should be determined in future experiments.